Previous close | 0.9200 |
Open | N/A |
Bid | 0.0000 |
Ask | 4.3000 |
Strike | 520.00 |
Expiry date | 2024-05-17 |
Day's range | 0.9200 - 0.9200 |
Contract range | N/A |
Volume | |
Open interest | N/A |
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
As you might know, Vertex Pharmaceuticals Incorporated ( NASDAQ:VRTX ) just kicked off its latest quarterly results...
Insightful Analysis of Vertex Pharmaceuticals' Financials and Strategic Positioning